By National Brain Tumor Society Joint initiatives aim to help patients and families navigate the era of precision medicine in cancer care
|
By Formaspace Read about the study that shows Osimertinib can help increase 5-year post-surgery survival rate for patients with Non-Small Cell Lung Cancel.
|
By Bharath Hospital Bharath Hospital is revolutionizing liver cancer treatment in central Kerala with advanced technology.
|
By WideTrial Basket trial of neoantigen synthetic long peptide vaccines for patients with advanced malignancy, run by the Jaime Leandro Foundation in association with Washington University of St. Louis
|